Cross-Reaction Antibody Test between SARS-CoV-2 and Dengue Hemorrhagic Fever in Indonesia

Authors

  • Danny Luhulima Faculty of Medicine, Christian University Indonesia, Jakarta/Mitra Keluarga Bekasi Timur Hospital, Jakarta
  • Tri Soetowo Mitra Keluarga Bekasi Timur Hospital, Jakarta
  • Ria Amelia STIKES Mitra Keluarga, Department of Laboratory Technology, Jakarta

DOI:

https://doi.org/10.24293/ijcpml.v27i2.1681

Keywords:

COVID-19, dengue hemorrhagic fever, cross-reaction

Abstract

Coronaviruses are a family of viruses that cause illness from the common cold to severe diseases such as Severe Acute Respiratory Syndrome (SARS-CoV). In December 2019, forty new cases of pneumonia of unknown etiology have been reported in Wuhan, China. The disease resembles Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and has been subsequently named the 2019-novel Coronavirus Disease (COVID-19). The antibody test is a blood test that provides quantitative and qualitative detection of IgG and IgM antibodies against the SARS-CoV-2. Reported a male, 43-year old
suffering from DHF, but the results of an IgG and IgM rapid test were COVID-19 reactive. Also, reviewed rapid tests for COVID-19 and the results showed that only IgG was reactive. This explained that the patient already had SARS Cov-2 antibodies but was not suffering from the disease. The rapid test COVID-19 IgM result was deemed to be a false positive.

Downloads

Download data is not yet available.

Author Biographies

Danny Luhulima, Faculty of Medicine, Christian University Indonesia, Jakarta/Mitra Keluarga Bekasi Timur Hospital, Jakarta

Faculty of Medicine, Christian University Indonesia, Jakarta/Mitra Keluarga Bekasi Timur Hospital, Jakarta

Tri Soetowo, Mitra Keluarga Bekasi Timur Hospital, Jakarta

Mitra Keluarga Bekasi Timur Hospital, Jakarta

Ria Amelia, STIKES Mitra Keluarga, Department of Laboratory Technology, Jakarta

STIKES Mitra Keluarga, Department of Laboratory Technology, Jakarta

References

To KKW, Tsang OTY, Leung WS, Tam AR, Wu TC, et al. Temporal profiles of viral load in posterior

oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: An

observational cohort study. Lancet Infect Dis, 2020; 20: 565–74. Available from: https://doi.org/10.1016/

S1473-3099(20)30196 (accessed 3 July, 2020).

Hoffman T, Nissen K, Krambrich J, Rönnberg G, Akaberi D, et al. Evaluation of a COVID-19 IgM and IgG

rapid test; An efficient tool for assessment of past exposure to SARS-CoV-2. Published by Informa UK

Limited, trading as Taylor & Francis Group. Available f r o m : h t t p s : / / d o i . o r g / 1 0 . 1 0 8 0 / 2 0 0 0 8 6 8 6 .2020.1754538 (accessed 4 July, 2020).

Tufan A. COVID-19, immune system response, hyper inflammation and repurposing antirheumatic drugs. Turk J Med Sci, 2020; 50: 620-632.

Hadi WS. Pemeriksaan laboratorium pada COVID-19, RSUP Soeradji Tirtonegoro. Available from: https: //rsupsoeradji.id/pemeriksaan-laboratorium-pada-covid-19/ (accessed 4 July, 2020).

Yan G, Lee CK, Lam LTM, Yan B, Chua YX, et al. Covert COVID-19 and false-positive dengue serology in

Singapore. The Lancet Infectious Diseases. Available from:https://www.thelancet.com/journals/laninf/

article/PIIS1473-3099(20)30158-4/fulltext (accessed 4 July, 2020).

Wu KC, Leddin D. Antibody testing for SARS-CoV-2: Role in management of the disease. Available from: ttps://www.worldgastroenterology.org/UserFiles/file/COVID19/AntibodytestingtoCOVIDv10.pdf?utm_source=WGO%20Website&utm_medium=Website&utm_campaign=COVID19Informationwebpage

_ COVID19_Antibodies (accessed 7 July, 2020).

Rahardjo B. High fluorescent lymphocyte count examination in dengue hemorrhagic patients with

Sysmex XN-1000 hematology analyzer. Indonesian Journal of Clinical Pathology and Medical laboratory,

; 25(2): 207-10. Available from: https://indonesianjournalofclinicalpathology.org/index.php/patologi/article/view/1443 (accessed 15 July, 2020).

Larantika H. Sensitivity and specificity of atipical lymphocyte for diagnosis of dengue virus at Mataram

th Hospital, West Nusa Tenggara. The 6 International Conference on Public Health, October 23-24, 2019.

A v a i l a b l e f r o m : h t t p s : / / d o i . o r g / 1 0 . 2 6 9 1 1 /the6thicph-FP.05.05.http://theicph.com/id_ID/2020/01/20/sensitivity-and-specificity-of-atypical-lymphocyte-for-diagnosis-of-dengue-virus-infection-at-mataram-hospital-west-nusa-tenggara-2/5-larantika_r1/ (accessed 8 February, 2021).

Maimunah S. Pemeriksaan antigen non-structural 1 sebagai deteksi dini infeksi akut virus. Essence of

Scientific Medical Journal, 2020; 17(2): 40-43.

Tan Li, Wang Qi, Zhang D, Ding J, Huang Q, et al. Lymphopenia predicts disease severity of COVID-19: A descriptive and predictive study. Signal Transduction and Targeted Therapy, 2020; 5: 33. Available from: h t t p s : / / w w w . g / c o n t e n t / 1 0 . 1 1 0 1 / 2 m e d r x i v .o r 0 2 0 . 0 3 . 0 1 . 2 0 0 2 9 0 7 4 v 1 . f u l l - t e x t ,https://doi.org/10.1038/s41392-020- 0148-4(accessed 7 July, 2020).

Erlina B. Pneumonia, COVID-19 diagnosis dan penatalaksanaan di Indonesia. Jakarta, Perhimpunan

Dokter Paru Indonesia (PDPI), 2020; 21-22. Available from https://covid19.idionline.org/wp-content/

uploads/2020/04/5.-Buku-PDPI-.pdf (accessed 9 July, 2020).

Yang AP, Liu JP, Tao WQ, Li HM. The diagnostic and predictive role of NLR, d-NLR, and PLR in COVID-19 patients. International Immunopharmacology, 2020; 84: 106504.

Downloads

Submitted

2020-09-20

Accepted

2021-01-11

Published

2021-04-15

How to Cite

[1]
Luhulima, D., Soetowo, T. and Amelia, R. 2021. Cross-Reaction Antibody Test between SARS-CoV-2 and Dengue Hemorrhagic Fever in Indonesia. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY. 27, 2 (Apr. 2021), 224–227. DOI:https://doi.org/10.24293/ijcpml.v27i2.1681.

Issue

Section

Case Report